VIH/SIDA

Oxfam has hailed the Indian Supreme Court’s ruling against a patent protection petition filed by multinational pharmaceutical company Novartis as a huge victory for public health.

 

 

Oxfam today praised the Medicine Patent Pool (MPP) for securing the first licenses for HIV medicines with the pharmaceutical company Gilead, a move that will boost the affordability and eff

HIV and AIDS women’s health advocates at the International AIDS Conference have criticized the lack of funding and policy support from international donors and governments for female condoms, which are a critical woman-initiated tool for fighting the HIV epidemic.

As preparations for the world AIDS conference in Vienna get underway, world leaders must take steps to provide immediate access to HIV and AIDS treatment, care and prevention for the millions of poor people who need it.

An Oxfam-commissioned survey reveals that sixty percent of rape victims were gang raped. More than half of the assaults took place in their own homes. There has also been a shocking increase in the number of civilian rapists.

International agency Oxfam today welcomed the prestigious Human Rights Award given to the South African HIV and AIDS organization the Treatment Action Campaign (TAC) by the Friedrich-Ebert-Stiftung/ Foundation.

Policy makers lament women’s vulnerablity to HIV infection, yet for 15 years they have failed to utilise a technology which can help women to protect and empower themselves.